BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update

Go back to BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
(NASDAQ: BBIO) Delayed: 75.51 +0.67 (0.90%)
Previous Close $74.84    52 Week High
Open $73.60    52 Week Low
Day High $76.34    P/E N/A 
Day Low $73.26    EPS
Volume 321,404